Gou Yu Lin, Ho Alice Lok Sze, Rowlands Dewi Kenneth, Chung Yiu Wa, Chan Hsiao Chang
Epithelial Cell Biology Research Center, Department of Physiology, The Chinese University of Hong Kong, Hong Kong.
Biol Pharm Bull. 2003 Feb;26(2):241-6. doi: 10.1248/bpb.26.241.
The effects of Bak Foong Pill (BFP, also known as Bai Feng Wan), a preparation of crude drugs in wide clinical use for treatment of gynecological disorders, on blood coagulation and platelet aggregation were investigated. The anticoagulant effect of BFP was evaluated by using thrombin time (TT), prothrombin time (PT), and activated partial thromboplastin time (APTT) assays. Results showed that BFP 70% ethanol extract (BFP-E-ext) significantly prolonged the TT in a dose-dependent manner with values of 17.6, 38.3, and 50.4 s at concentrations of 4.0, 6.0, and 12.0 mg/ml, respectively. Whereas, the BFP-E-ext did not show significant prolonging effect in PT and APTT assays. The results suggest that the anticoagulant effect of BFP is mediated by directly blocking thrombin, the key enzyme in the blood coagulation cascade. BFP-E-ext significantly inhibited platelet aggregation induced by collagen and adenosine diphosphate (ADP) with inhibition percentages of 74 and 52% at a concentration of 6.0 mg/ml, respectively, whereas, it exhibited a weak inhibitory activity on platelet aggregation induced by archidonic acid (AA). Comparing to BFP-E-ext, the effects of BFP aqueous extract (BFP-W-ext) on both anticoagulant and antiplatelet activities were significantly less potent. Moreover, the effects of the 26 ingredients of BFP on blood coagulation and platelet aggregation were separately evaluated with 19 ingredient herbs exhibiting anticoagulant effect and 10 exhibiting antiplatelet effect. The anticoagulant and antiplatelet effects of BFP were collectively demonstrated by in vivo assays showing prolonged bleeding times after BFP treatment for two weeks. The results of the present studies may provide explanations for beneficial effects of BFP on the circulation and indicate its potential use for cardiovascular diseases.
研究了妇科临床广泛应用的中药制剂白凤丸(BFP,又称白凤丸)对血液凝固和血小板聚集的影响。通过凝血酶时间(TT)、凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)试验评估了白凤丸的抗凝作用。结果显示,白凤丸70%乙醇提取物(BFP-E-ext)以剂量依赖方式显著延长TT,在浓度为4.0、6.0和12.0mg/ml时,TT值分别为17.6、38.3和50.4秒。然而,BFP-E-ext在PT和APTT试验中未显示出显著的延长作用。结果表明,白凤丸的抗凝作用是通过直接阻断凝血级联反应中的关键酶凝血酶来介导的。BFP-E-ext显著抑制胶原蛋白和二磷酸腺苷(ADP)诱导的血小板聚集,在浓度为6.0mg/ml时,抑制率分别为74%和52%,而对花生四烯酸(AA)诱导的血小板聚集表现出较弱的抑制活性。与BFP-E-ext相比,白凤丸水提取物(BFP-W-ext)的抗凝和抗血小板活性均显著较弱。此外,分别评估了白凤丸26种成分对血液凝固和血小板聚集的影响,其中19种成分具有抗凝作用,10种具有抗血小板作用。体内试验表明,白凤丸治疗两周后出血时间延长,共同证明了其抗凝和抗血小板作用。本研究结果可为白凤丸对循环系统的有益作用提供解释,并表明其在心血管疾病中的潜在应用价值。